Buchanan et al (42) | OPrT | Schz. Schzaff | 14 | 43.1 (7.2) | ? | 6 | 10 | Olanzapine | Not clearly reported | BPRS, SANS, Digit Symbol, RAVLT, BVRT, CPT, GPT‡ |
Stryjer et al (44) | OPrT | Schz. comorbid dementia | 6 | 65 (?) | ? | 4 | 5 | Clotiapine, haloperidol, olanzapine, risperidone | Allowed | MMSE,§ PANSS,NS ADAS-cog, CGI (S&I)§ |
Erickson et al (45) | RCT | Schz. Schzaff | 15 | 43 (5.2) | ? | 18 | 5 | Chlorpromazine, clozapine, fluphenazine, haloperidol, olanzapine, quetiapine, risperidone | Allowed | PANSS,NS TMTNS (A&B), RAVLT‡ |
Freudenreich et al (46) | RCT | Schz. | 36 | 48.7 (?) | 80 | 8 | 10 | Aripiprazole, fluphenazine, haloperidol, olanzapine, quetiapine, risperidone, ziprazidone | NA | PANSS, SANS,CDSS, Digit Span, TMT (A&B), HVLT-R, BOWAT, GPT |
Friedman et al (47) | RCT | Schz. | 36 | 48.8 (11.1) | 78 | 12 | 5 or 10 | Risperidone | NA | PANSS, CPT,NS Digit Span, SSWMT, TMT (A&B), WCST, RAVLT Verbal fluency |
Mazeh et al (48) | RCT (Crossover) | Schz. comorbid dementia | 17 | 70.2 (6.51) | ? | 24 | 10 | Clozapine, fluphenazine, haloperidol, olanzapine, penfluridol, perphenazine, risperidone, ziprasidone, zuclopenthixol | Allowed | PANSS, ADAS-cog, CGI |
Nahas et al (49) | RCT (Crossover) fMRI | Schz. Schzaff | 6 | 36.8 (11) | ? | 12 | 10 | Olanzapine, risperidone | NA | PANSS, COWATNS |
Tugal et al (50) | RCT (Crossover) | Schz. | 12 | 38 (10.2) 29.2 (5.9) | ? | 12 | 5 | Fluphenazine, pimozide | NA | PANSS, CDSS WMS-R,¶ TMT (A&B), WCST, WAIS-Block design, WHO-verbal fluency |